About
Matis Medical's Cone and Plate(let) Analyzer (CPA) is a point-of-care system for real-time, whole-blood platelet function testing. The company's first two products are the Impact and the Impact-R. The company has performed an extensive body of studies that demonstrated the Impact's success in screening forcongenital primary hemostasis abnormalities and testing platelet response to GPIIb-IIIa antagonists, aspirin, and clopidogrel. The Impact system for clinical and point-of-care laboratories is in development and is not commercially available. Matis Medical was founded in 2000. The CPA technology was invented by Prof. David Varon and Prof. Naphtali Savion and patented through Ramot, the Authority for Applied Research & Industrial Development of the Tel Aviv University, Israel. Ramot granted Matis Medical exclusive rights for the worldwide commercialization of the technology for all applications.
Q&A
- What is Matis Medical's primary focus?
- Matis Medical focuses on whole-blood platelet function testing, developing a point-of-care system called the Cone and Plate(let) Analyzer (CPA).
- What are the main products developed by Matis Medical?
- Matis Medical's primary products are the Impact and the Impact-R systems, which are designed for real-time, whole-blood platelet function testing.
- When was Matis Medical founded?
- Matis Medical was founded in 2000.
- What is the current status of Matis Medical?
- Matis Medical is currently inactive, with its status changed in November 2016.
- Where is Matis Medical headquartered?
- Matis Medical is headquartered in Ramat Gan, Center District, Israel.
- What is the employee count for Matis Medical?
- Matis Medical has an employee count in the 1-10 range.
- What is the current funding stage of Matis Medical?
- Matis Medical is currently in the Pre-Funding stage.
- What is the origin of Matis Medical's core technology?
- The CPA technology was invented by Prof. David Varon and Prof. Naphtali Savion and patented through Ramot, the Authority for Applied Research & Industrial Development of Tel Aviv University, Israel. Matis Medical was granted exclusive worldwide commercialization rights for the technology.
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2000-1 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Non Active, Nov 2016 |